LISATA THERAPEUTICS, INC. Payments to Acquire Marketable Securities
LISATA THERAPEUTICS, INC. (LSTA) reported Payments to Acquire Marketable Securities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2025 was $9.18M, a 83.52% decline from fiscal 2024.
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2024 was $55.69M, a 43.45% decline from fiscal 2023.
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2023 was $98.48M, a 9.80% increase from fiscal 2022.
- LISATA THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2022 was $89.69M, a 50.11% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 3 month as first filed | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $4.13M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $4.13M derived: sum of 3 quarters · filed 2026-08-06 | $9.18M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.13M derived: sum of 2 quarters · filed 2026-08-06 | $9.18M 10-Q · filed 2025-11-06 | $20.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.18M 10-Q · filed 2026-08-06 | $20.91M derived: sum of 3 quarters · filed 2026-08-06 | $36.35M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $5.05M 10-Q · filed 2026-05-11 | $16.79M derived: sum of 2 quarters · filed 2026-05-11 | $32.23M derived: sum of 3 quarters · filed 2026-05-11 | $41.92M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $11.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $27.17M derived: sum of 2 quarters · filed 2026-03-12 | $36.86M derived: sum of 3 quarters · filed 2026-03-12 | $55.69M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $15.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $25.13M derived: sum of 2 quarters · filed 2025-11-06 | $43.95M 10-Q · filed 2025-11-06 | $65.08M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $28.52M 10-Q · filed 2025-08-07 | $49.64M derived: sum of 3 quarters · filed 2025-08-07 | $66.16M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $18.82M 10-Q · filed 2025-05-08 | $39.95M derived: sum of 2 quarters · filed 2025-05-08 | $56.47M derived: sum of 3 quarters · filed 2025-05-08 | $87.18M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $21.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $37.64M derived: sum of 2 quarters · filed 2025-02-27 | $68.36M derived: sum of 3 quarters · filed 2025-02-27 | $98.48M 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $16.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $47.23M derived: sum of 2 quarters · filed 2024-11-12 | $77.36M 10-Q · filed 2024-11-12 | $98.56M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $30.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $60.84M 10-Q · filed 2024-08-12 | $82.04M derived: sum of 3 quarters · filed 2024-08-12 | $120.23M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $30.12M 10-Q · filed 2024-05-09 | $51.33M derived: sum of 2 quarters · filed 2024-05-09 | $89.52M derived: sum of 3 quarters · filed 2024-05-09 | $93.26M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $21.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $59.40M derived: sum of 2 quarters · filed 2024-02-29 | $63.14M derived: sum of 3 quarters · filed 2024-02-29 | $89.69M 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | $38.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $41.94M derived: sum of 2 quarters · filed 2023-11-02 | $68.48M 10-Q · filed 2023-11-02 | $110.93M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $30.29M 10-Q · filed 2023-08-14 | $72.74M derived: sum of 3 quarters · filed 2023-08-14 | $104.27M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $26.55M 10-Q · filed 2023-05-09 | $68.99M derived: sum of 2 quarters · filed 2023-05-09 | $100.53M derived: sum of 3 quarters · filed 2023-05-09 | $130.41M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $42.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $73.98M derived: sum of 2 quarters · filed 2023-03-30 | $103.86M derived: sum of 3 quarters · filed 2023-03-30 | $179.78M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $31.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $61.42M derived: sum of 2 quarters · filed 2022-11-10 | $137.33M 10-Q · filed 2022-11-10 | $150.31M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $29.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $105.79M 10-Q · filed 2022-08-04 | $118.77M derived: sum of 3 quarters · filed 2022-08-04 | $132.36M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $75.91M 10-Q · filed 2022-05-05 | $88.89M derived: sum of 2 quarters · filed 2022-05-05 | $102.47M derived: sum of 3 quarters · filed 2022-05-05 | $110.71M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $12.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $26.56M derived: sum of 2 quarters · filed 2022-03-22 | $34.80M derived: sum of 3 quarters · filed 2022-03-22 | $34.80M 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $13.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $21.82M derived: sum of 2 quarters · filed 2021-11-04 | $21.82M 10-Q · filed 2021-11-04 | $22.45M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $8.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $8.23M 10-Q · filed 2021-08-05 | $8.86M derived: sum of 3 quarters · filed 2021-08-05 | $15.20M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $626.00K derived: sum of 2 quarters · filed 2021-05-06 | $6.97M derived: sum of 3 quarters · filed 2021-05-06 | $16.67M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $6.97M derived: sum of 2 quarters · filed 2021-02-25 | $16.67M derived: sum of 3 quarters · filed 2021-02-25 | $32.94M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | $6.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $16.05M derived: sum of 2 quarters · filed 2020-11-05 | $32.31M 10-Q · filed 2020-11-05 | $41.81M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $9.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $25.97M 10-Q · filed 2020-08-13 | $35.47M derived: sum of 3 quarters · filed 2020-08-13 | $57.34M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $16.26M 10-Q · filed 2020-05-07 | $25.76M derived: sum of 2 quarters · filed 2020-05-07 | $47.63M derived: sum of 3 quarters · filed 2020-05-07 | $61.81M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $31.37M derived: sum of 2 quarters · filed 2020-03-05 | $45.55M derived: sum of 3 quarters · filed 2020-03-05 | $69.69M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $21.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $36.05M derived: sum of 2 quarters · filed 2019-11-06 | $60.19M 10-Q · filed 2019-11-06 | $60.19M 10-Q · filed 2018-11-08 | $68.62M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2018-06-30 | $14.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $38.32M 10-Q · filed 2019-08-08 | $38.32M 10-Q · filed 2018-08-09 | $46.75M derived: sum of 3 quarters · filed 2019-08-08 | $62.06M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $24.14M 10-Q · filed 2019-05-09 | $24.14M 10-Q · filed 2018-05-10 | $32.58M derived: sum of 2 quarters · filed 2019-05-09 | $47.88M derived: sum of 3 quarters · filed 2019-05-09 | $84.30M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $23.74M derived: sum of 2 quarters · filed 2019-03-14 | $60.16M derived: sum of 3 quarters · filed 2019-03-14 | $60.16M 10-K · filed 2019-03-14 | $60.16M 10-K · filed 2018-03-22 | |||
| 2017-09-30 | $15.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $51.72M derived: sum of 2 quarters · filed 2018-11-08 | $51.72M 10-Q · filed 2018-11-08 | $51.72M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $36.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $36.42M 10-Q · filed 2018-08-09 | $36.42M derived: sum of 3 quarters · filed 2018-08-09 | $36.42M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-05-10 | $0.00 derived: sum of 3 quarters · filed 2018-05-10 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 10-K · filed 2018-03-22 | |||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-10 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $3.07M derived: sum of 2 quarters · filed 2017-03-17 | $6.08M 10-K · filed 2017-03-17 | |||||
| 2015-09-30 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $6.08M 10-Q · filed 2016-11-07 | ||||||
| 2015-06-30 | $3.01M 10-Q · filed 2016-08-09 | |||||||
| 2014-12-31 | $7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $7.12M derived: sum of 2 quarters · filed 2016-03-15 | $8.04M 10-K · filed 2016-03-15 | |||||
| 2014-09-30 | $500.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $920.33K 10-Q · filed 2015-11-05 | ||||||
| 2014-06-30 | $919.83K 10-Q · filed 2015-08-06 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | |||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $0.00 10-Q · filed 2014-10-30 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 | |||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |